Gyre Therapeutics, Inc. GYRE Gyre — Net Segment Loss Income

Similar metrics at other companies

PTLOSegment — Net income (loss)

$7.2M-28.0%

ARVNReportable Segment — Segment net (loss) income

-$57.6M-169%

RDVTSegments — Net Income Loss

$4.96M+84.7%

MBLYAll Other Segments — Segment Income Loss

-$1M+50.0%

SNOWReportable Segment — Net income (loss)

-$295.57M+31.3%

MRVLReportable Segment — Net income (loss)

$34.5M-80.6%

FAQ

What is Gyre Therapeutics, Inc.'s gyre — net segment loss income?

Gyre Therapeutics, Inc. (GYRE) reported gyre — net segment loss income of -$8.62M in Q2 2026.

What does gyre — net segment loss income mean?

This metric reflects the final net financial result for the business segment after all revenues and expenses, including non-operating items, have been considered. It provides a comprehensive view of the segment's total contribution to the company's bottom line. Investors use this to evaluate the overall financial health and net impact of the segment's operations on the parent company's consolidated performance.